[
    {
        "id": "osp-12946",
        "type": "article-journal",
        "title": "Pars plana Baerveldt tube insertion with pars plana vitrectomy for refractory glaucoma",
        "author": [
            {
                "family": "Kolomeyer",
                "given": "Anton M"
            },
            {
                "family": "Kim",
                "given": "H Jane"
            },
            {
                "family": "Khouri",
                "given": "Albert S"
            },
            {
                "family": "Lama",
                "given": "Paul J"
            },
            {
                "family": "Fechtner",
                "given": "Robert D"
            },
            {
                "family": "Zarbin",
                "given": "Marco A"
            },
            {
                "family": "Bhagat",
                "given": "Neelakshi"
            }
        ],
        "URL": "https://omanscience.com/en/articles/pars-plana-baerveldt-tube-insertion-with-pars-plana-vitrectomy-for-refractory-glaucoma",
        "language": "en",
        "issued": {
            "date-parts": [
                [
                    2012
                ]
            ]
        },
        "container-title": "Oman Journal of Ophthalmology",
        "volume": "5",
        "issue": "1",
        "page": "19-27",
        "DOI": "10.4103/0974-620x.94762",
        "publisher": "Medknow Publications",
        "ISSN": "0974-620X",
        "abstract": "Background: Glaucoma drainage implants (GDIs) are used for managing recalcitrant glaucoma and are usually placed in the anterior chamber. This approach may lead to complications such as corneal decompensation, and so a pars plana approach is used in at risk eyes.\n\nAims: To compare functional outcomes and complications of 250 mm(2) and 350 mm(2) pars plana Baerveldt tube insertion with pars plana vitrectomy (PPV) (both 20- and 23-gauge) for managing refractory glaucoma.\n\nSettings and design: A retrospective chart review of 38 patients (39 eyes) undergoing combined PPV-Baerveldt procedure for glaucoma recalcitrant to maximal medical treatment or previous filtering procedures with >6 weeks of follow-up.\n\nMaterials and methods: Main outcome measures were visual acuity, intraocular pressure (IOP), number of glaucoma medications, and postoperative complications.\n\nStatistical analysis used: A paired 't' test was used to evaluate changes in IOP and glaucoma medications, Fisher's exact test was used to compare complication rates, and Kaplan-Meier survival curves were constructed for comparison of overall outcomes.\n\nResults: Mean patient age was 62.2 years. Mean follow-up period was 33.7 months, with 36 (92%) eyes followed for ≥6 months. Mean±SD preoperative IOP and number of glaucoma medications were significantly reduced by the combined procedure (P"
    }
]